Cite
HARVARD Citation
Yokota, K. et al. (n.d.). 3325 Safety and efficacy of Pembrolizumab (MK-3475) for Japanese patients (pts) with advanced melanoma: Preliminary results from KEYNOTE-041 Phase 1b study. European journal of cancer. pp. S672-. [Online].